Enefexine
Overview of the drug Enefexine
| Enefexine | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Enefexine is a chemical compound that has been investigated for its potential use as an antidepressant. It belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs), which are used to treat major depressive disorder and other mood disorders by increasing the levels of serotonin and norepinephrine in the brain.
Pharmacology[edit]
Enefexine functions primarily by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters that play a crucial role in mood regulation. By preventing the reabsorption of these neurotransmitters into the presynaptic neuron, enefexine increases their availability in the synaptic cleft, thereby enhancing neurotransmission and improving mood.
Mechanism of Action[edit]
The mechanism of action of enefexine involves the blockade of the serotonin transporter (SERT) and the norepinephrine transporter (NET). This dual inhibition is thought to contribute to its antidepressant effects. Unlike some other SNRIs, enefexine may have a more balanced effect on both neurotransmitters, potentially leading to a more favorable side effect profile.
Clinical Development[edit]
Enefexine has undergone various stages of clinical trials to assess its efficacy and safety in treating depression. However, as of the latest updates, it has not been approved for clinical use. The development of enefexine has provided valuable insights into the treatment of depression and the role of neurotransmitter modulation in mood disorders.
Side Effects[edit]
As with other SNRIs, potential side effects of enefexine may include nausea, dizziness, insomnia, dry mouth, and increased sweating. The side effect profile is an important consideration in the development and approval of new antidepressants.
Potential Benefits[edit]
The potential benefits of enefexine, if approved, would include its use as an alternative treatment for patients who do not respond adequately to existing antidepressants. Its balanced action on serotonin and norepinephrine reuptake could offer advantages in terms of efficacy and tolerability.
Research and Future Directions[edit]
Research into enefexine continues to explore its pharmacological properties and potential therapeutic applications. Future studies may focus on optimizing its efficacy, minimizing side effects, and understanding its long-term impact on patients with depression.
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian